Trial Profile
Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Dec 2018
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 27 Nov 2018 Status changed from active, no longer recruiting to discontinued.
- 24 May 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Mar 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.